Amvuttra, illustration of pre-filled syringe form (not a photo of the actual pack)

Illustrative image.

Amvuttra

Vutrisiran

Prescription required

$166475.00

25mg/0.5ml · 1 · 3 months supply

BrandBranded medicine· By Alnylam Pharmaceuticals

$55491.67 per month

How long a supply?

3 months$55491.67 a month
6 months$55491.67 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$665900a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

About Amvuttra

Overview

Amvuttra contains vutrisiran, a medicine for adults with transthyretin-mediated amyloidosis. It treats nerve damage (polyneuropathy) caused by the hereditary form of this condition. It also treats heart muscle disease (cardiomyopathy) caused by hereditary or wild-type transthyretin-mediated amyloidosis, to reduce cardiovascular deaths, cardiovascular hospitalizations and urgent heart failure visits. It works by breaking down the genetic messages used to make transthyretin, reducing this protein in the blood and its deposits in tissues.

What it treats

- Polyneuropathy (nerve damage) caused by hereditary transthyretin-mediated amyloidosis in adults. - Cardiomyopathy (heart muscle disease) caused by wild-type or hereditary transthyretin-mediated amyloidosis in adults, to reduce cardiovascular death, cardiovascular hospital admissions and urgent heart failure visits.

Safety information

Side effects

Common side effects of Amvuttra include pain in the arms or legs, joint pain, shortness of breath and reduced vitamin A levels. Each was reported in at least 5% of patients. Reduced vitamin A levels are an important safety concern. Contact your doctor if you develop eye symptoms that could suggest vitamin A deficiency; the label recommends referral to an eye specialist. Vitamin A supplementation is recommended during treatment, ask your prescriber for guidance.

When to call your doctor

• Seek medical attention if you have difficulty breathing. • Contact your doctor promptly if you develop eye symptoms, as these may signal low vitamin A levels and need assessment by an eye specialist.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

The FDA label lists no contraindications for Amvuttra. Amvuttra can lower vitamin A levels in the blood. Vitamin A supplementation is recommended; your prescriber should advise on the amount. If eye symptoms suggestive of vitamin A deficiency occur, referral to an eye specialist is recommended.

Using Amvuttra

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store in the original carton to protect it from light. Check the pack for whether it must be refrigerated before first use. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label AMVUTTRA (VUTRISIRAN) INJECTION [ALNYLAM PHARMACEUTICALS, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines